Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

IROA Technologies, University of Florida Announce Biomarker Collaboration

Published: Wednesday, July 02, 2014
Last Updated: Wednesday, July 02, 2014
Bookmark and Share
Company will support the University of Florida in a collaborative search for biomarkers of liver cancer and other liver diseases.

The collaboration will leverage the University of Florida’s Clinical and Translational Science Institute (CTSI) Biorepository, which contains a diverse collection of normal and diseased human tissues and may be used for IRB-approved research.  In addition, UF’s Southeast Center for Integrated Metabolomics (SECIM) will provide state-of the-art metabolic profiling using the IROA protocol as a foundation for exploring liver biochemical diversity and disease response.

Felice de Jong, CEO of IROA Technologies, stated, “We are pleased to be both a partner at SECIM where clients can send IROA samples for metabolic profiling analysis and now a collaborator within CTSI for biomarker discovery.  We are thrilled to be working with two such significant units within the University of Florida.  We feel this strength will assure a high probability of success. ”

IROA Technologies and UF will focus on analyzing and validating clinical tissue biomarkers in liver cancer and fatty liver disease, de Jong said, adding that UF will provide medical support and interpretation of results through an established expert liver disease and mass spectrometry Advisory Committee.  Beyond the initial discovery phases, the ability of CTSI and SECIM to support all levels of validation and testing will be critical to the long-term success of this endeavor.  

"The partnership with IROA Technologies and Dr. Chris Beecher will allow UF to develop novel methods for the identification of biomarkers for human disease. UF and the CTSI are now uniquely positioned to advance and translate metabolomics to improve health for millions of Americans," said David R. Nelson, M.D., an assistant vice president for research at UF and director of the UF CTSI.  "The relationship between IROA Technologies and SECIM keeps us at the cutting edge of new and powerful metabolomics technologies,” said Art Edison, Ph.D., Director of SECIM.

Financial and other terms of the agreement were not disclosed.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!